Array BioPharma: Fiscal 2Q Earnings Snapshot
BOULDER, Colo. (AP) _ Array BioPharma Inc. (ARRY) on Tuesday reported a loss of $11.4 million in its fiscal second quarter.
The Boulder, Colorado-based company said it had a loss of 5 cents per share.
The results beat Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 16 cents per share.
The drug developer posted revenue of $82.5 million in the period, which also topped Street forecasts. Six analysts surveyed by Zacks expected $49 million.
Array BioPharma shares have climbed 33 percent since the beginning of the year. The stock has increased 27 percent in the last 12 months.